Assembled and directed a team of professionals to respond to a legislative initiative in Massachusetts that would have imposed tighter controls on an internationally marketed prescription drug. On behalf of our client, a leading international pharmaceutical company, we brought together a public relations team, with statehouse lobbying support, to combat the action. By preparing the regulatory filings and developing the overall case strategy, our team was able to implement a plan that resulted in no change to the drug's classification. |